Welcome to Multibagg AI
Log in to access personalized features
Portfolio
Alerts
Ask Iris
Discovery
Timeline
Multibagg AI is an AI powered stock research and analysis platform. We provide data, information, content, and analytics for publicly traded Indian companies listed on NSE and BSE. AI can make mistakes, check important information.
Prices might be delayed by a few minutes.
Join our Exclusive Community
Join our Exclusive Community
Made with 💙 in India. © Finsky Technologies Pvt Ltd. 2026
Get instant AI-powered insights about company performance, financials, and strategy. Ask questions about trends, competition, and developments while receiving responses backed by official documents and market data, with clear attribution to source documents.
Discover detailed, AI-driven financial summaries that break down key metrics, trends, and insights—empowering you to make smarter investment decisions.
View Standalone
View Standalone
View Standalone
View Standalone
View Standalone
View Standalone
View Standalone
View Standalone
Bearish
3
Neutral
7
Bullish
4
Bearish
18
Neutral
7
Bullish
21
Bearish
15
Neutral
0
Bullish
17
Discovery themes featuring this stock
Galaxy Surfactants manufactures surfactants and specialty care ingredients for global Home and Personal Care customers, operating manufacturing facilities in India, Egypt and the USA and serving over 1,500 clients with a portfolio exceeding 215 products across Performance Surfactants and Specialty Care segments.
Q3 FY26 delivered INR124 crore consolidated EBITDA (before exceptional items), up 13% year-on-year, and an improved EBITDA per tonne of INR20,156, driven by strong TRI‑K specialty performance, non‑Tier‑1 customer growth and operational cost initiatives despite multiple contemporaneous headwinds.
A major structural positive arrived with the bilateral reduction of reciprocal U.S. tariffs on Indian exports from 50% to 18%; Galaxy expects this to materially restore competitiveness for India-origin specialty exports, accelerate pipeline conversions in North America, and improve pricing flexibility and margins over coming quarters.
Galaxy faced concurrent headwinds: reformulation by a Tier‑1 Indian customer reduced Performance Surfactants volumes, GST rationalization prompted temporary domestic demand disruption, AMET region lost share to backward‑integrated local players, and oleochemical feedstock volatility—especially fatty alcohol spreads—kept reformulation risk elevated.
Strategic product and brand moves include Strategy 2030 launches (five new GalSORB and SunBliss variants in sun care and leave‑on segments), a corporate rebrand in January 2026, and continued R&D/patent activity, positioning Galaxy to expand higher‑margin specialty and beauty ingredient revenue from Q4 FY26 onwards.
Chemicals & Petrochemicals
Specialty Chemicals
6,857 Cr
Moderate Risk
24.7
44.1
-2.8
2.5
2,750.00
1,512.30
Sales CAGR
Profit CAGR
ROE
ROCE
Discovery themes featuring this stockGalaxy Surfactants Ltd (GALAXYSURF) is currently trading at 1,933.95 per share. Stock prices fluctuate during market hours on NSE and BSE based on demand, company updates, and overall market conditions. Refer to the live price chart above for the most recent price movement.
Galaxy Surfactants manufactures surfactants and specialty care ingredients for global Home and Personal Care customers, operating manufacturing facilities in India, Egypt and the USA and serving over 1,500 clients with a portfolio exceeding 215 products across Performance Surfactants and Specialty Care segments. Q3 FY26 delivered INR124 crore consolidated EBITDA (before exceptional items), up 13% year-on-year, and an improved EBITDA per tonne of INR20,156, driven by strong TRI‑K specialty performance, non‑Tier‑1 customer growth and operational cost initiatives despite multiple contemporaneous headwinds. A major structural positive arrived with the bilateral reduction of reciprocal U.S. tariffs on Indian exports from 50% to 18%; Galaxy expects this to materially restore competitiveness for India-origin specialty exports, accelerate pipeline conversions in North America, and improve pricing flexibility and margins over coming quarters. Galaxy faced concurrent headwinds: reformulation by a Tier‑1 Indian customer reduced Performance Surfactants volumes, GST rationalization prompted temporary domestic demand disruption, AMET region lost share to backward‑integrated local players, and oleochemical feedstock volatility—especially fatty alcohol spreads—kept reformulation risk elevated. Strategic product and brand moves include Strategy 2030 launches (five new GalSORB and SunBliss variants in sun care and leave‑on segments), a corporate rebrand in January 2026, and continued R&D/patent activity, positioning Galaxy to expand higher‑margin specialty and beauty ingredient revenue from Q4 FY26 onwards.
Over the past 52 weeks, Galaxy Surfactants Ltd has traded between a low of ₹1,512.30 and a high of ₹2,750.00. The 52-week high and low indicate the stock’s price range over the last year and help investors understand its volatility and recent trading levels.
Galaxy Surfactants Ltd has a market capitalization of approximately 6,856.77. Market capitalization represents the total value of a company’s outstanding shares and helps investors understand its size, stability, and relative risk compared to other listed companies.
Galaxy Surfactants Ltd’s investment profile depends on its business fundamentals, valuation, and long-term outlook. The stock currently trades at a PE ratio of 24.66 and operates in the its sector sector. Investors typically assess financial performance, growth prospects, and individual risk tolerance before making investment decisions.
Based on its market capitalization of 6,856.77 Cr, Galaxy Surfactants Ltd is classified as a Small Cap stock. Large-cap stocks are generally more stable, while mid-cap and small-cap stocks tend to offer higher growth potential along with higher price volatility.
Galaxy Surfactants Ltd operates in the its sector sector. Sector classification matters because companies in the same sector are often affected by similar economic conditions, regulatory changes, and competitive dynamics, which can influence overall stock performance.
The Price-to-Earnings (PE) ratio of Galaxy Surfactants Ltd is 24.66. The PE ratio compares a company’s share price to its earnings and is commonly used to assess valuation. Comparing the PE ratio with sector peers and historical levels provides better context.
| Symbol | Watchlist | Price | Market Cap | P/E | P/B | Div Yield (%) | ROE (%) | ROCE (%) | ROA (%) |
721.50 | 7,662 Cr | 33.36 | 4.84 | 0.55 | 14.50 | 19.52 | 12.88 | ||
9310.00 | 7,365 Cr | 50.45 | 7.31 | 0.08 | 14.66 | 19.67 | 12.52 | ||
2248.90 | 7,067 Cr | 42.31 | 3.58 | 0.50 | 8.46 | 11.24 | 6.17 | ||
1933.95 | 6,857 Cr | 24.66 | 2.50 | 1.14 | 9.74 | 12.15 | 6.90 | ||
557.00 | 6,848 Cr | 66.50 | 3.54 | 0.45 | 5.52 | 7.20 | 3.96 | ||
2063.65 | 5,650 Cr | 196.51 | 5.78 | 0.05 | 3.52 | 5.24 | 1.23 | ||
181.90 | 5,054 Cr | 63.30 | 2.55 | 0.16 | 4.00 | 4.35 | 2.30 | ||
| Median: 7 Co. | — | 1933.95 | 6,857 Cr | 50.45 | 3.58 | 0.45 | 8.46 | 11.24 | 6.17 |
Regulatory/Compliance Filing
Galaxy Surfactants Ltd: Nomination & Remuneration Committee granted 8,400 stock options under PSOP-2025 on July 22, 2026. Exercise price Rs.10; vesting after AGM for FY2028-29; no options vested or exercised as on date.
Regulatory/Compliance Filing
Galaxy Surfactants Ltd: Nomination & Remuneration Committee approved grant of 8,400 stock options under PSOP-2025 on July 22, 2026. Exercise price Rs.10; vesting after AGM for FY2028-29. No options vested or exercised as on date.
